Herantis Pharma to Participate in the Upcoming Investor and Partnering Conference
Herantis Pharma Plc, Press Release, 8 March 2022 at 09:00 EET Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that Antti Vuolanto, Chief Operating Officer, will hold a company presentation at: Sachs 5th Annual Neuroscience Innovation Forum (Virtual) The presentation will be held on March 22, 2022 1x1 meetings will be scheduled with the management team during March 21 – 25, 2022 The presentation will be available via a digital library, which is accessible to event participants only. Please contact the conference